Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

161. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management Full Text available with Trip Pro

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management To update clinical practice guidelines to assist primary care (PC) clinicians in the management of adolescent depression. This part of the updated guidelines is used to address practice preparation, identification, assessment, and initial management of adolescent depression in PC settings.By using a combination of evidence- and consensus-based (...) methodologies, guidelines were developed by an expert steering committee in 2 phases as informed by (1) current scientific evidence (published and unpublished) and (2) draft revision and iteration among the steering committee, which included experts, clinicians, and youth and families with lived experience.Guidelines were updated for youth aged 10 to 21 years and correspond to initial phases of adolescent depression management in PC, including the identification of at-risk youth, assessment and diagnosis

2018 EvidenceUpdates

162. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. (Abstract)

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Treatment-resistant major depressive disorder is common; repetitive transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side dorsolateral prefrontal cortex stimulation is an evidence-based treatment for this disorder. Intermittent theta burst stimulation (iTBS) is a newer form of rTMS that can (...) , ON, and University of British Columbia Hospital, Vancouver, BC). Participants were aged 18-65 years, were diagnosed with a current treatment-resistant major depressive episode or could not tolerate at least two antidepressants in the current episode, were receiving stable antidepressant medication doses for at least 4 weeks before baseline, and had an HRSD-17 score of at least 18. Participants were randomly allocated (1:1) to treatment groups (10 Hz rTMS or iTBS) by use of a random permuted block method

2018 Lancet Controlled trial quality: predicted high

163. Antidepressants for preventing postnatal depression. Full Text available with Trip Pro

Antidepressants for preventing postnatal depression. Depression is common in the postnatal period and can lead to adverse effects on the infant and wider family, in addition to the morbidity for the mother. It is not clear whether antidepressants are effective for the prevention of postnatal depression and little is known about possible adverse effects for the mother and infant, particularly during breastfeeding. This is an update of a Cochrane Review last published in 2005.To assess (...) the effectiveness of antidepressant medication for the prevention of postnatal depression, in comparison with any other treatment, placebo or standard care.We searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR ‒ both Studies and References), CENTRAL (Wiley), MEDLINE (OVID), Embase (OVID), PsycINFO (OVID), on 13 February 2018. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov on 13 February 2018 to identify any additional unpublished

2018 Cochrane

164. FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression

FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression - Faculty of Sexual and Reproductive Healthcare FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression Share this article Posted 8 March 2018 Date: 08 Mar 2018 Type: FSRH Clinical Guidance (...) and Clinical Statements This statement responds to a recent study that reported that the bulk of evidence does not support an association between progestogen-only contraception (POC) and depression. The study has received media attention and the FSRH CEU considers it important to monitor and report on emerging evidence. A systematic review published in Contraception reported that women who had used progestogen-only contraception (POC) were no more likely to experience depression than women not using POC

2018 Faculty of Sexual & Reproductive Healthcare

165. Delivering Clinical Practice Guideline-Concordant Care for PTSD and Major Depression in Military Treatment Facilities Full Text available with Trip Pro

Delivering Clinical Practice Guideline-Concordant Care for PTSD and Major Depression in Military Treatment Facilities Providing accessible, high-quality care for psychological health (PH) conditions, such as posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), is important to maintaining a healthy, mission-ready force. It is unclear whether the current system of care meets the needs of service members with PTSD or MDD, and little is known about the barriers to delivering

2018 Rand health quarterly

166. Quality of Care for PTSD and Depression in the Military Health System: Final Report Full Text available with Trip Pro

Quality of Care for PTSD and Depression in the Military Health System: Final Report The U.S. Department of Defense (DoD) strives to maintain a physically and psychologically healthy, mission-ready force, and the care provided by the Military Health System (MHS) is critical to meeting this goal. Attention has been directed to ensuring the quality and availability of programs and services for posttraumatic stress disorder (PTSD) and depression. This study is a comprehensive assessment (...) of the quality of care delivered by the MHS in 2013-2014 for over 38,000 active-component service members with PTSD or depression. The assessment includes performance on 30 quality measures to evaluate the receipt of recommended assessments and treatments. These measures draw on multiple data sources including administrative encounter data, medical record review data, and patient self-reported outcome monitoring data. The assessment identified strengths and areas for improvement for the MHS. In particular

2018 Rand health quarterly

167. Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer Full Text available with Trip Pro

Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer The aim of this study was to investigate the impacts of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer.The study was performed on 90 patients diagnosed with breast cancer and 90 healthy women. Sociodemographic and Clinical Data Collection Form designed by us, Beck Hopelessness Scale (BHS), Beck (...) Anxiety Scale (BAS), Beck Depression Scale (BDS), Eysenck Personality Inventory (EPI) and Quality of Life Scale-Short Form (SF-36) were administered to patients and to control group.The patients with breast cancer were found to indicate higher levels of anxiety and depression, lower levels of quality of life, and higher scores of personality inventory subscales as compared to the healthy control group. In the patient group, it was identified that the quality of life subscale scores were found

2018 European journal of breast health

168. Season of birth and depression in adulthood: Revisiting historical forerunner evidence for in-utero effects Full Text available with Trip Pro

Season of birth and depression in adulthood: Revisiting historical forerunner evidence for in-utero effects Evidence showing a relationship between season of birth and adult well-being is long-standing, but is now largely overlooked or dismissed. In light of increasingly compelling evidence for the effects of in-utero conditions on adult health, however, it is instructive to revisit the relationship, with an eye toward resolving the reasons for skepticism. This study uses data from the first (...) National Health and Nutritional Examination Survey to examine the effects of month of birth on adult depression. The data correspond to an important time in history and the analysis points to one reason why enthusiasm for birth seasonality in depression has faded: although there was a strong relationship between month of birth and depression in the early 20th century, with spring and summer month births corresponding to significantly more depression, the relationship was largely eliminated by the 1940

2018 SSM - population health

169. Identifying perinatal depression with case-finding instruments: a mixed methods study (BaBY PaNDA - Born and Bred in Yorkshire PeriNatal Depression Diagnostic Accuracy) Full Text available with Trip Pro

Identifying perinatal depression with case-finding instruments: a mixed methods study (BaBY PaNDA - Born and Bred in Yorkshire PeriNatal Depression Diagnostic Accuracy) Identifying perinatal depression with case-finding instruments: a mixed methods study (BaBY PaNDA - Born and Bred in Yorkshire PeriNatal Depression Diagnostic Accuracy) Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested (...) could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} The Whooley and EPDS instruments had acceptable diagnostic accuracy in identifying perinatal depression, though their use may be limited by variation in acceptability and neither met National Screening Committee criteria. {{author}} {{($index

2018 NIHR HTA programme

170. Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants Full Text available with Trip Pro

Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants Adolescents with depression identified in primary care settings often have limited treatment options beyond antidepressant (AD) therapy. We assessed the cost-effectiveness of a brief cognitive behavioral therapy (CBT) program among depressed adolescents who declined or quickly stopped using ADs.A total of 212 youth with depression were randomly assigned to treatment as usual (TAU) or TAU plus brief (...) individual CBT. Clinical outcomes included depression-free days (DFDs) and estimated quality-adjusted life-years (QALYs). Costs were adjusted to 2008 US dollars. Incremental cost-effectiveness ratios (ICERs) comparing CBT to TAU were calculated over 12- and 24-month follow-up periods.Youth randomly assigned to CBT had 26.8 more DFDs (P = .044) and 0.067 more QALYs (P = .044) on average compared with TAU over 12 months. Total costs were $4976 less (P = .025) by the end of the 24-month follow-up among

2018 EvidenceUpdates

171. Depression from the perspective of modern and Persian medicine Full Text available with Trip Pro

Depression from the perspective of modern and Persian medicine Depression is one of the five most-common diseases globally, and is expected to be the second leading cause of disability by 2020 and its economic and social burden is a major problem worldwide.The aim of this research was to elucidate the causes and symptoms of depression according to Persian Medicine (PM) and classic medicine.In this study, works that were investigated were the Canon of Medicine, Al-Hawi Fi Teb, Kamel Al-Sina'a (...) be considered. According to manuscripts some mental-emotional events in life can cause these changes. They independently may cause depression. Semiologically some symptoms and signs happen consequently to in the above-mentioned causes which are in common with depression signs and symptoms including grief, crying, low libido, weight loss, appetite and sleep disorders, exhaustion, slow cognitive processing, indecisiveness and willingness to die.The major biological causes of depression is a group

2018 Electronic physician

172. Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data Full Text available with Trip Pro

Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data To determine the cost of depression comorbidity among Japanese adults with rheumatoid arthritis (RA).A retrospective database study of 8968 patients diagnosed with RA between 2010 and 2015 and treated with any RA medication was conducted. Health care utilization characteristics were compared between patients with and without a comorbidity of depression. Propensity score matching was applied (...) to ensure a balanced comparison between the two cohorts.The prevalence of a depression comorbidity was found for 5% of the total RA patients. This comorbidity was associated with 62% (56%) higher total outpatient visits and 66% (163%) higher rate of emergency room visits after 6 (12) months.Burden of depression among RA patients in Japan is relatively high and awareness for depression as a comorbidity of RA needs to be reinforced.Janssen Pharmaceutical KK.

2018 Rheumatology and therapy

173. Factors associated with depression in patients with type 2 diabetes in the Gaza Strip: a cross sectional study. Full Text available with Trip Pro

Factors associated with depression in patients with type 2 diabetes in the Gaza Strip: a cross sectional study. About 9% of the world's population has diabetes. Most people with diabetes live in developing countries. Diabetes is the fourth leading cause of death in the occupied Palestinian territory. The likelihood of diabetes complications increases with depression. Worldwide, about half of patients with diabetes have severe depression that has been misidentified by health providers. The aim (...) of this study was to examine factors associated with depression in patients with type 2 diabetes in the Gaza governorate.This cross-sectional study included patients attending three primary health centres in 2016. A convenient purposive approach to sampling was used to select three centres from the 15 centres in the Gaza governorate, covering the east (border), middle, and west areas. Since 2014, all patients with type 2 diabetes have been screened for depression using the Patient Health Questionnaire 9

2018 Lancet

174. Depression in patients treated with haemodialysis: a cross-sectional study. Full Text available with Trip Pro

Depression in patients treated with haemodialysis: a cross-sectional study. The increasing incidence of end-stage renal disease in the Palestinian population and the effect of the disease on the psychological status of the patient underlie the importance of increasing knowledge about the mental health status of patients with end-stage renal disease. The aim of this study was to estimate the prevalence of depression in Palestinian patients treated with haemodialysis and its correlation (...) with patients' clinical characteristics, health-related quality of life (HRQoL), and adherence to medications.In this cross-sectional study, we collected a convenience sample from ten haemodialysis centres in the West Bank, occupied Palestinian territory, over 3 months in 2015. The Beck Depression Inventory-II scale (BDI-II) was used to assess depression, the EuroQol-5 Dimension scale was used to assess HRQoL, and the Morisky Medication Adherance-8 scale was used to assess compliance. We used SPSS version

2018 Lancet

175. Association of alterations in smell and taste with depression in older adults Full Text available with Trip Pro

Association of alterations in smell and taste with depression in older adults Examine the relationship between depression and changes in smell or taste.Cross-sectional analysis of 2011-2012 and 2013-2014 National Health and Nutrition Examination Survey (NHANES).We examined 5,275 adults ≥40 years old who completed smell and taste questionnaires as well as a validated depression assessment instrument, the Patient Health Questionnaire (PHQ-9). Analyses incorporated sampling weights to account (...) for the complex sampling design and associations were analyzed using multivariate logistic regression adjusted for related demographics and socioeconomic data.The prevalence of altered smell and taste was 23.0% (95% CI: 20.7-25.3%) and 11.9% (95% CI: 10.7-13.1%), respectively. Among those who met criteria for major depressive disorder, the prevalence of altered smell and taste was higher at 39.8% (95% CI: 33.4-46.1%) and 23.7% (95% CI: 18.7-28.7%), respectively. In a multivariate model adjusting for age

2018 Laryngoscope investigative otolaryngology

176. Inverted items and validity: A psychobiological evaluation of two measures of psychological resources and one depression scale Full Text available with Trip Pro

Inverted items and validity: A psychobiological evaluation of two measures of psychological resources and one depression scale Psychological resources and risk factors influence risk of coronary heart disease. We evaluated whether inverted items in the Self-esteem, Mastery, and Center for Epidemiological Studies Depression scales compromise validity in the context of coronary heart disease. In a population-based sample, validity was investigated by calculating correlations with other scales (n (...)  = 1004) and interleukin-6 (n = 374), and by analyzing the relationship with 8-year coronary heart disease risk (n = 1000). Negative items did not affect the validity of the resource scales. In contrast, positive items from Center for Epidemiological Studies Depression showed no significant relationships with biological variables. However, they had no major impact on the validity of the original scale.

2018 Health psychology open

177. Orbital and medial prefrontal cortex functional connectivity of major depression vulnerability and disease Full Text available with Trip Pro

Orbital and medial prefrontal cortex functional connectivity of major depression vulnerability and disease Pathophysiology models of major depression (MD) center on the dysfunction of various cortical areas within the orbital and medial prefrontal cortex. While independent structural and functional abnormalities in these areas are consistent findings in MD, the complex interactions among them and the rest of the cortex remain largely unexplored.We used resting-state functional magnetic

2018 Biological psychiatry. Cognitive neuroscience and neuroimaging

178. Longer initial assessment in primary care when depression is suspected

Longer initial assessment in primary care when depression is suspected Longer initial assessment in primary care when depression is suspected We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Longer initial assessment in primary care when depression is suspected Share: Reading time approx. 1 minute Symptoms of depression is a common cause (...) for patients consulting general practitioners in primary care. To be able to correctly diagnose depression at the initial assessment a thorough and thus time-consuming examination is needed. The assessment also needs to be documented with a test questionnaire. This is to understand the severity but also to initiate a relevant treatment and to plan the follow up. Question Are there any scientific studies that support that a longer initial assessment results in less pharmacological treatment and faster

2018 Swedish Council on Technology Assessement

179. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial Full Text available with Trip Pro

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial Pharmacotherapy to rapidly relieve suicidal ideation in depression may reduce suicide risk. Rapid reduction in suicidal thoughts after ketamine treatment has mostly been studied in patients with low levels of suicidal ideation. The authors tested the acute effect of adjunctive subanesthetic intravenous ketamine on clinically significant suicidal ideation in patients with major (...) depressive disorder.In a randomized clinical trial, adults (N=80) with current major depressive disorder and a score ≥4 on the Scale for Suicidal Ideation (SSI), of whom 54% (N=43) were taking antidepressant medication, were randomly assigned to receive ketamine or midazolam infusion. The primary outcome measure was SSI score 24 hours after infusion (at day 1).The reduction in SSI score at day 1 was 4.96 points greater for the ketamine group compared with the midazolam group (95% CI=2.33, 7.59; Cohen's d

2018 EvidenceUpdates

180. Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation

Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Health Quality Ontario. Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2017 Authors' conclusions The Ontario Health Technology Advisory Committee recommends that evidence-based, structured, individual and group psychotherapy provided by nonphysicians be publicly funded for patients with major depressive disorder and/or generalized anxiety disorder Final publication URL Indexing Status

2018 Health Technology Assessment (HTA) Database.